Healthcare -
Biotechnology - NASDAQ - US
$ 40.58
-1.27 %
$ 3.14 B
Market Cap
-312.15
P/E
VCYT - COST OF REVENUE
Cost of Revenue VCYT - Veracyte, Inc.
113 M
LAST VALUE
23.19%
2 YEAR CAGR
27.83%
5 YEAR CAGR
24.51%
10 YEAR CAGR